Sonoma Pharmaceuticals (SNOA) EPS (Basic) (QoQ) (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.15 Mn | -184,359.87 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.13% |
| Mar 31, 2026 | 27.84% |
| Dec 31, 2025 | -47.37% |
| Sep 30, 2025 | 57.10% |
| Jun 30, 2025 | -20.94% |
| Mar 31, 2025 | 1.35% |
| Dec 31, 2024 | -7.45% |
| Sep 30, 2024 | 56.05% |
| Jun 30, 2024 | 42.82% |
| Mar 31, 2024 | -47.87% |
| Dec 31, 2023 | 99.97% |
| Sep 30, 2023 | -0.19% |
| Jun 30, 2023 | 25.39% |
| Mar 31, 2023 | 38.49% |
| Dec 31, 2022 | -90.66% |
| Sep 30, 2022 | -114,593.13% |
| Sep 30, 2021 | 91.87% |
| Jun 30, 2021 | -359.26% |
| Mar 31, 2021 | -876.65% |
| Dec 31, 2020 | 24.24% |